Overnutrition has emerged as a major public health issue in India. Being overweight or obese lowers immunity and has been linked to non-communicable diseases (NCDs), which in turn is associated with vulnerability and severe illness due to COVID. This paper investigates the association of overnutrition indicators with COVID prevalence and case fatality rates in India. Analysis of data from the nationally representative dataset National Family Health Survey-5 and COVID data shows that overnutrition is significantly associated with NCDs and, therefore, overnutrition indicators are also utilised as a surrogate for NCDs. District-level analysis indicates strong and significant relationships between overnutrition and COVID prevalence and fatality rate. Results underscore the importance of addressing obesity in general for successful NCDs prevention strategies, targeting messages of COVID prevention among obese individuals as well as the development of additional vaccination strategies for COVID that take into account the link between COVID and obesity.
AgrawalU., KatikireddiS. V., McCowanC., MulhollandR. H., Azcoaga-LorenzoA., AmeleS., FagbamigbeA. F., VasileiouE., GrangeZ., ShiT., KerrS., MooreE., MurrayJ. L. K., ShahS. A., RitchieL., O’ReillyD., StockS. J., BeggsJ., ChuterA., & SheikhA. (2021). COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): A prospective cohort study. The Lancet Respiratory Medicine, 9(12), 1439–1449.
2.
BadawiA., & RyooS. G. (2016). Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis. International Journal of Infectious Diseases, 49, 129–133.
3.
CaussyC., WalletF., LavilleM., & DisseE. (2020). Obesity is associated with severe forms of COVID‐19. Obesity, 28(7), 1175–1175.
4.
CDC COVID Response Team, ChowN., Fleming-DutraK., GierkeR., HallA. J., HughesM. M., PilishviliT., RitcheyM. D., RoguskiK. M., SkoffT. H., & UsseryE.(CDC). (2020). Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States. Morbidity and Mortality Weekly Report, 69(13), 382–386.
5.
ChhabraP., & ChhabraS. K. (2007). Distribution and determinants of body mass index of non-smoking adults in Delhi, India. Journal of Health, Population, and Nutrition, 25(3), 294.
6.
DaganN., BardaN., KeptenE., MironO., PerchikS., KatzM. A., HernánM. A., LipsitchM., ReisB., & BalicerR. D. (2021). BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. New England Journal of Medicine, 384(15), 1412–1423.
7.
DangA., MaitraP., & MenonN. (2019a). Labor market engagement and the body mass index of working adults: Evidence from India. Economics & Human Biology, 33, 58–77.
8.
DangA., MaitraP., & MenonN. (2019b). The geography of excess weight in urban India: Regional patterns and labour market and dietary correlates. InDisease, human health, and regional growth and development in Asia (pp. 47–69). Springer.
9.
DeatonA., & DrèzeJ. (2009). Food and nutrition in India: Facts and interpretations. Economic and Political Weekly, 44(7), 42–65.
10.
EliS., & LiN. (2015). Caloric requirements and food consumption patterns of the poor (No. w21697). National Bureau of Economic Research.
11.
EliakimA., SwindtC., ZaldivarF., CasaliP., & CooperD. M. (2006). Reduced tetanus antibody titers in overweight children. Autoimmunity, 39(2), 137–141.
12.
GhoshS. M., & QadeerI. (2017). Calorie intake and quality of diet in India: 1993–94 to 2011–12. Social Scientist, 45(9/10), 13–34.
13.
GriffithsP. L., & BentleyM. E. (2001). The nutrition transition is underway in India. The Journal of Nutrition, 131(10), 2692–2700.
14.
HolmanN., KnightonP., KarP., O’KeefeJ., CurleyM., WeaverA., BarronE., BakhaiC., KhuntiK., WarehamN. J., SattarN., YoungB., & ValabhjiJ. (2020). Risk factors for COVID-related mortality in people with type 1 and type 2 diabetes in England: A population-based cohort study. The Lancet Diabetes & Endocrinology, 8(10), 823–833.
15.
KarlssonE. A., MilnerJ. J., GreenW. D., RebelesJ., Schultz-CherryS., & BeckM. A. (2019). Influence of obesity on the response to influenza infection and vaccination. InMechanisms and manifestations of obesity in lung disease (pp. 227–259). Academic Press.
16.
KulkarniV. S., KulkarniV., & GaihaR. (2014). Double burden of malnutrition: Why are Indian women likely to be underweight and obese?Brooks World Poverty Institute Working Paper, 190.
17.
LawC., GreenR., Suneetha KadiyalaB. S., KnaiC., BrownK. A., DangourA. D., & CornelsenL. (2019). Purchase trends of processed foods and beverages in urban India. Global Food Security, 23, 191.
18.
LighterJ., PhillipsM., HochmanS., SterlingS., JohnsonD., FrancoisF., & StachelA. (2020). Obesity in patients younger than 60 years is a risk factor for COVID hospital admission. Clinical Infectious Diseases, 71(15), 896–897.
19.
LouieJ. K., AcostaM., SamuelM. C., SchechterR., VugiaD. J., HarrimanK., & MatyasB. T. (2011). A novel risk factor for a novel virus: Obesity and 2009 pandemic influenza A (H1N1). Clinical Infectious Diseases, 52(3), 301–312.
20.
MeenakshiJ. V. (2016). Trends and patterns in the triple burden of malnutrition in India. Agricultural Economics, 47(S1), 115–134.
21.
MenonN. (2021). Does BMI predict the early spatial variation and intensity of Covid-19 in developing countries? Evidence from India. Economics & Human Biology, 41, 100990.
22.
MesserliF. (1982). Cardiovascular effects of obesity and hypertension. The Lancet, 319(8282), 1165–1168.
23.
MiñanaJ. S., GanuzaM. G., MillánP. F., & FernándezM. P. (1996). Hepatitis B vaccine immunoresponsiveness in adolescents: A revaccination proposal after primary vaccination. Vaccine, 14(2), 103–106.
24.
MokdadA. H., FordE. S., BowmanB. A., DietzW. H., VinicorF., BalesV. S., & MarksJ. S. (2003). Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA, 289(1), 76–79.
25.
MuniyappaR., & WilkinsK. J. (2020). Diabetes, obesity, and risk prediction of severe COVID. The Journal of Clinical Endocrinology & Metabolism, 105(10), e3812–e3814.
26.
NeidichS. D., GreenW. D., RebelesJ., KarlssonE. A., Schultz-CherryS., NoahT. L., ChakladarS., HudgensM. G., WeirS. S., & BeckM. A. (2017). Increased risk of influenza among vaccinated adults who are obese. International Journal of Obesity, 41(9), 1324–1330.
27.
NFHS-5, India fact sheet. (2022). http://rchiips.org/nfhs/NFHS-5_FCTS/India.pdf
28.
NFHS-4, India fact sheet. (2016). http://rchiips.org/nfhs/pdf/NFHS4/India.pdf
29.
NFHS-4, State fact sheet. (2016). http://rchiips.org/nfhs/pdf/NFHS4/India.pdf
30.
O’RourkeR. W., & LumengC. N. (2020). Pathways to severe COVID‐19 for people with obesity. Obesity, 29(4), 645–653.
31.
PelliniR., VenutiA., PimpinelliF., AbrilE., BlandinoG., CampoF., ContiL., De VirgilioA., De MarcoF., Di DomenicoE. G., & Di BellaO. (2021). Obesity may hamper SARS-CoV-2 vaccine immunogenicity. medRxiv. https://www.medrxiv.org/content/10.1101/2021.02.24.21251664v1
32.
Pi-SunyerX. (2009). The medical risks of obesity. Postgraduate Medicine, 121(6), 21–33.
33.
PopkinB. M., DuS., GreenW. D., BeckM. A., AlgaithT., HerbstC. H., AlsukaitR. F., AlluhidanM., AlazemiN., & ShekarM. (2020). Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships. Obesity Reviews, 21(11), e13128.
34.
PopkinB. M., HortonS., KimS., MahalA., & ShuigaoJ. (2001). Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: The economic costs of the nutrition transition. Nutrition Reviews, 59(12), 379–390.
35.
PoulainM., DoucetM., MajorG. C., DrapeauV., SérièsF., BouletL. P., TremblayA., & MaltaisF. (2006). The effect of obesity on chronic respiratory diseases: Pathophysiology and therapeutic strategies. CMAJ, 174(9), 1293–1299.
36.
RamachandranP. (2014). Triple burden of malnutrition in India: Challenges and opportunities. IDFC Foundation. India Infrastructure Report, 14.
37.
SalvatorH., Grassin-DelyleS., NalineE., BrolloM., FournierC., CoudercL. J., & DevillierP. (2020). Contrasting effects of adipokines on the cytokine production by primary human bronchial epithelial cells: Inhibitory effects of adiponectin. Frontiers in Pharmacology, 11, 56.
38.
SharmaM., KishoreA., RoyD., & JoshiK. (2020). A comparison of the Indian diet with the EAT-Lancet reference diet. BMC Public Health, 20, 1–13.
39.
ShettyP. (2013). Nutrition transition and its health outcomes. The Indian Journal of Pediatrics, 80(1), 21–27.
40.
SiddiquiZ., & DonatoR. (2020). The dramatic rise in the prevalence of overweight and obesity in India: Obesity transition and the looming health care crisis. World Development, 134, 105050.
41.
SimonnetA., ChetbounM., PoissyJ., RaverdyV., NouletteJ., DuhamelA., LabreucheJ., MathieuD., PattouF., & VerkindtH. (2020). High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity, 28(7), 1195–1199.
42.
SinghG. M., DanaeiG., FarzadfarF., StevensG. A., WoodwardM., WormserD., KaptogeS., WhitlockG., QiaoQ., LewingtonS., & Di AngelantonioE. (2013). The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: A pooled analysis. PloS One, 8(7), e65174.
43.
SubramanianS. V., PerkinsJ. M., & KhanK. T. (2009). Do burdens of underweight and overweight coexist among lower socioeconomic groups in India?The American Journal of Clinical Nutrition, 90(2), 369–376.
44.
ViswanathanB., & AgnihotriA. (2020). Double burden of malnutrition in India: Decadal changes among adult men and women. No. 2020-200.
45.
WeberD. J., RutalaW. A., SamsaG. P., SantimawJ. E., & LemonS. M. (1985). Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA, 254(22), 3187–3189.
46.
WuZ., & McGooganJ. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019(COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. https://jamanetwork.com/journals/jama/fullarticle/2762130
47.
ZhangY., CuiY., ShenM., ZhangJ., LiuB., DaiM., ChenL., HanD., FanY., ZengY., LiW., LinF., LiS., ChenX., & PanP. (2020). Association of diabetes mellitus with disease severity and prognosis in COVID: A retrospective cohort study. Diabetes Research and Clinical Practice, 165, 108227.
48.
ZhengK. I., GaoF., WangX. B., SunQ. F., PanK. H., WangT. Y., MaH. L., ChenY. P., LiuW. Y., GeorgeJ., & ZhengM. H. (2020). Obesity as a risk factor for greater severity of COVID in patients with metabolic-associated fatty liver disease. Metabolism, 108, 15424.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
